ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105509 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105509; 2) Community: the network communities that were significantly associated with the response to NSC 105509; 3) Molecule: the relationships between components within communities and NSC 105509; 4) MDR: the compounds that were significantly associated with the NSC 105509.

NSC Compound Enrichment Correlation
NSC 136468 Null 0.0420420371076614 -0.11076174
NSC 150311 2-Propenone, 1-(4-bromophenyl)-2-(4-morpholinylmethyl)-3-phenyl-, hydrobromide, (Z)- 0.0420420371076614 -0.26458473
NSC 175633 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- 0.0420420371076614 -0.23366914
NSC 295501 Camptothecin Derivative 0.0420420371076614 -0.004714942
NSC 320877 Geldanamycin, 17-[(2-chloroethyl)amino]-17-demethoxy- 0.0420420371076614 -0.28870348
NSC 46683 Null 0.0420420371076614 -0.115401
NSC 52427 Null 0.0420420371076614 -0.025286843
NSC 623081 Null 0.0420420371076614 0.16405393
NSC 623527 Pyrrolidinium, N-(5-carboxypentyl)-N- [2-[2-[3-(octadecyloxy)-2-[(pyrimidine-2yl)oxy]propyloxy] ethoxy]ethyl]-, inner salt 0.0420420371076614 -0.089586318
NSC 645265 Null 0.0420420371076614 -0.20834301
Total:57  Current:47    [First] [Prev] [Next] [Last]